Related references
Note: Only part of the references are listed.European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 Update
J. Maertens et al.
BONE MARROW TRANSPLANTATION (2011)
Classification of invasive fungal disease in patients with acute myeloid leukaemia
Christina T. Rieger et al.
MYCOSES (2011)
Posaconazole prophylaxis in patients with acute myelogenous leukaemia - results from an observational study
G. Egerer et al.
MYCOSES (2011)
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort
J. J. Vehreschild et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
Oliver A. Cornely et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies
Jutta Auberger et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients
Christina T. Rieger et al.
MYCOSES (2008)
Fungal infections in recipients of hematopoietic stem cell transplants: Results of the SEIFEM B-2004 study - Sorveglianza epidemiologica infezioni fungine nelle emopatie maligne
L. Pagano et al.
CLINICAL INFECTIOUS DISEASES (2007)
Invasive aspergillosis in patients with acute leukemia: Update on morbidity and mortality SEIFEM-C report
Livio Pagano et al.
CLINICAL INFECTIOUS DISEASES (2007)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
Oliver A. Cornely et al.
CLINICAL INFECTIOUS DISEASES (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies
Johan Maertens
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies:: a meta-analysis of randomised-controlled trials
KZ Vardakas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants
FM Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole
A Imhof et al.
CLINICAL INFECTIOUS DISEASES (2004)
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance
KA Marr et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2004)
Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors -: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
OA Cornely et al.
ANNALS OF HEMATOLOGY (2003)
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
OA Cornely et al.
BLOOD (2003)
Aspergillosis - Pathogenesis, clinical manifestations, and therapy
KA Marr et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Towards a targeted, risk-based, antifungal strategy in neutropenic patients
HG Prentice et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
